Why Bother?

Why Bother?

“Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to a proposed follow-on public offering of approximately $50 million of its common stock. All of the shares to be sold in the offering will be offered by Tandem . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.